For instance, dormant lung cancer cells exhibit drug-resistant phenotypes with a characteristic inhibition of the ERK1/2 and Akt pathways that explain the downregulation of tumor progression and invasion genes (uPA, uPAR, MMP2, MMP7, MMP9, and CXCR4) [74]. The gene discussed is PLAU; the disease is neoplasm.